Group Sequential Methods with Applications to Clinical Trials

By KyungMann Kim. 2001

960 citations recorded by the source corpus.

Subfields: Economics and Econometrics, Immunology, Pediatrics, Perinatology and Child Health

View Paper: https://www.semanticscholar.org/paper/0df5653858b0a3badcde421be00bb407dee0384e

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Economics and Econometrics

In Immunology

In Pediatrics, Perinatology and Child Health

Citations in the corpus

Uniform, nonparametric, non-asymptotic confidence sequences (2018, methodology): “Siegmund (1978) gave an early analytical treatment of the problem; numerical methods are also available for group sequential tests (Jennison and Turnbull, 2000, §8.5).”
Adaptive increase in sample size when interim results are promising: A practical guide with examples (2011, methodology): “Using standard group-sequential methods (for example, Jennison and Turnbull [12]) we can construct a two-stage, one-sided, level- , group sequential trial with futility boundary (a1), efficacy”
Time-uniform, nonparametric, nonasymptotic confidence sequences (2018, methodology): “A very different approach is that of group sequential methods (Pocock, 1977; O’Brien and Fleming, 1979; Lan and DeMets, 1983; Jennison and Turnbull, 2000).”
Time-uniform central limit theory and asymptotic confidence sequences (2021, methodology): “2, 3, 7, 8, 23, 25, 32, 54, 59, 65 [20] Christopher Jennison and Bruce W Turnbull.”
Sequential-Design, Multicenter, Randomized, Controlled Trial of Early Decompressive Craniectomy in Malignant Middle Cerebral Artery Infarction (DECIMAL Trial) (2007, neutral): “Patients at home 3 (100) 6 (86) 1 (20) 2 (50)”
Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening (2011, positive): “Efficacy and futility boundaries were built on the Lan–DeMets approach with an O’Brien–Fleming spending function.(20) Interim analyses were performed annually from 2006 through 2009 and semiannually in 2010.”
Dynamic treatment regimes (2009, methodology): “Standard test statistics (Hoel 1984) and sample size formula (Jennison and Turnbull 2000) for a large sample comparison of two means can be used in this case.”
Trial Sequential Analysis in systematic reviews with meta-analysis (2017, methodology): “If the number of randomised participants in the meta-analysed trials is less than the required, the confidence interval needs to be adjusted [34, 36].”
Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidone: The antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT) (2000, background): “Relative risks and P values should not be overinterpreted because the comparison between doxazosin and chlorthalidone was terminated earlier than scheduled.(3) The DSMB met semiannually to review the accumulating data and to monitor the trial for either superiority or inferiority of the 3 agents com”
Small Sample Size Solutions (2020, methodology): “To keep the Type I error risk over all decisions acceptable, the Type I error rate for individual decisions must be adjusted (Jennison & Turnbull, 1999).”
Implementing Optimal Allocation in Sequential Binary Response Experiments (2007, background): “These optimality criteria are a K-treatment generalization of the form studied by Jennison and Turnbull (2000).”
Application of Bayesian Approach in Cancer Clinical Trial (2014, background): “The Bayesian is best fitted approach to deal with random effects [11, 12].”